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ABSTRACT  Platelet-derived growth factor B (PDGF-B) belongs to the mitogen and growth factor 
family and like the other members it has many roles in cell differentiation, proliferation and migration 
during development, adult life and in pathological conditions. Among them it has been observed 
that aberrant PDGF signalling is frequently linked to glioma development and progression, and 
Pdgf-b over-expression in mouse neural progenitors leads to the formation of gliomas. Despite this 
evidence, the mechanisms underlying PDGF-B driven tumorigenesis and its role during brain devel-
opment are not fully understood. In order to contribute to clarifying possible new roles of pdgf-b 
signalling, we present here the embryonic gene expression pattern of pdgf-b, so far unknown in early 
vertebrate development. By using Xenopus laevis as a model system we performed qRT-PCR and 
whole mount in situ hybridization. Pdgf-b mRNA is expressed in discrete regions of the developing 
central nervous system, in the cranial nerve placodes and in the notochord. We also compared the 
gene expression of pdgf-b with that of its receptor pdgfr-a suggesting so far unsuspected roles for 
this signalling pathway during the development of specific embryonic structures. 
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Platelet-derived growth factor (PDGF) family comprises two tyrosine 
kinase receptors (PDGFR-a and -b) and four ligands (PDGF-A, 
-B, -C, and -D) that form homodimers or the heterodimer AB 
(Demoulin and Essaghir, 2014). The active ligand-receptor com-
plex consists of two receptor chains associated with one dimeric 
ligand. While PDGFR-a binds to all PDGF isoforms except for 
PDGF-DD, PDGFR-b binds only to PDGF-BB and -DD (Fig.1). 
Also a heterodimeric ab receptor has been reported that binds to 
PDGF-AB, -BB and possibly -CC and –DD (Demoulin and Essaghir, 
2014). The members of this family have been extensively studied 
for more than 30 years in development, adult homeostasis and 
disease (Heldin, 2013, Heldin, 2014, Hoch and Soriano, 2003). 
Pdgf-a expression was recently characterized in mouse tissues 
and in early embryonic development, showing its involvement in 
developmental processes including gastrulation and craniofacial 
development (Andrae et al., 2014, Eberhart et al., 2008). On the 
contrary, for pdgf-b the only information available mainly concern 
its role during embryonic angiogenesis (Hoch and Soriano, 2003, 
Leveen et al., 1994), and a complete gene expression pattern in 
vertebrate embryogenesis is still lacking. Functional studies using 
a knock out mouse for pdgf-b showed abnormal kidney glomeruli, 
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heart and blood vessel dilation, anemia, thrombocytopenia, haemor-
rhages and perinatal death (Betsholtz, 1995, Leveen et al., 1994). 
However, in this mutant line, BB homodimer and AB heterodimer 
were simultaneously abrogated, making difficult to precisely define 
the specific role of pdgf-b alone during embryogenesis. Further-
more, due to extensive perinatal haemorrhages, other possible 
phenotypes caused by the lack of pdgf-b in specific tissues could 
not be deeply investigated. 
It is known that pdgf-b possesses a C-terminal basic retention 
motif, which binds to extracellular matrix components. The presence 
of this motif does not prevent binding to the receptor but limits the 
pdgf-b diffusion. When the retention motif is removed by intracel-
lular or extracellular proteases, a soluble and diffusible pdgf-b form 
is released. Recently, the study of mutant mice harboring a pdgf-b 
gene that lacks the retention motif shed light on its importance, 
showing that the mutant mice present an intermediary phenotype 
between wild-type and pdgf-b knock-out animals (Demoulin and 
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Essaghir, 2014). The interplay between pdgf-bb and the extracel-
lular matrix has been also demonstrated in many cell types, for 
instance, in dermal fibroblasts pdgf-b stimulates the synthesis of 
hyaluronan, which in turn is required for the mitogenic activity of 
pdgf-b, via the activation of CD44 receptor (Li et al., 2007).
Another interesting aspect of studying PDGF family function 
relies on the fact that over activity of PDGF signalling is associ-
ated with several malignant and non-malignant diseases (Heldin, 
2013, Heldin, 2014). Among malignant ones it was shown that in 
gliomas, a group of heterogeneous and aggressive brain tumours, 
alteration of PDGF signalling is commonly observed (Calzolari and 
Malatesta, 2010); interestingly PDGF-B over-expression alone was 
shown inducing oligodendroglioma, a specific subclass of glioma, 
from mouse neural progenitors, suggesting a crucial role for this 
molecule in tumorigenesis (Appolloni et al., 2009). Moreover recent 
data about the cellular mechanisms of PDGF-B driven glioma pro-
gression and maintenance indicate that PDGF may be required to 
override cell contact inhibition and promote glioma cell infiltration 
(Calzolari and Malatesta, 2010). Nevertheless not much is known 
about the molecular mechanisms activated downstream PDGF-B 
signalling. A deeper comprehension of pdgf-b role during devel-
opment might help in shedding light on its mechanisms of action 
in modulating different aspects of cell behaviour also involved in 
tumorigenesis and tumour progression. 
Results and Discussion
PDGF-b s expressed during Xenopus laevis development
The aim of this work was to describe the gene expression pat-
tern of pdgf-b during embryogenesis using Xenopus laevis as a 
model. Xenopus is a tetrapod from the same evolutionary branch 
of mammals and because of its external embryonic development, it 
represents a suitable model to study in details the expression pat-
tern of a specific gene from the very early steps of embryogenesis. 
We firstly performed qRT-PCR comparing the relative expression 
level of pdgf-b with that of its receptor pdgfr-a already described 
(Bae et al., 2014) (Fig. 2). Pdgf-b mRNA is present as a maternal 
transcript within the blastula at 4 cells stage (stage 3 according to 
Nieuwkoop and Faber, 1967). After the start of the zygotic transcrip-
tion (stage 8), pdgf-b mRNA was barely detectable and it showed 
a low expression level both during gastrulation (stage 10.5) and 
neurulation (stage 13); on the contrary, pdgfr-a was abundantly 
expressed at these stages. During gastrulation in Xenopus, a crucial 
role for pdgf-a and pdgfr-a has been demonstrated (Damm and 
Winklbauer, 2011). As pdgf-b mRNA is extremely poorly expressed 
during gastrulation, this data corroborates the idea that in the early 
phases of development, the main role of PDGF signalling is played 
by the homodimer pdgf-aa via pdgfr-a. This is in line with the ob-
servation that in pdgf-a morphants the prechordal mesoderm fails 
to spread during gastrulation and no compensatory mechanisms 
occurs (Damm and Winklbauer, 2011). At the end of neurulation 
(Stage 20), pdgf-b mRNA expression level rose and then decreased 
again at late tailbud stages (stage 35) (Fig. 2). 
In order to define the localization of pdgf-b mRNA, we performed 
whole mount in situ hybridization (WISH) using a digoxigenin la-
belled pdgf-b antisense RNA probe on wild type Xenopus embryos 
at different stages of development (Figs. 3-4). We confirmed the 
presence of pdgf-b as a maternal transcript at stage 3, when the 
mRNA is localized in the animal pole (Fig. 3A). In the gastrulating 
embryo, pdgf-b was faintly expressed in the animal pole in the 
deep layer of the ectodermal blastocoel roof (Fig. 3 B-B’). In these 
early phases of development the riboprobes could sometimes 
generate false positive signals due to the unspecific labelling of the 
blastocoel cavity. We therefore confirmed the specificity of pdgf-b 
mRNA localization performing the same WISH experiment using 
a pdgf-b sense riboprobe (Fig. 3 A*-B*-B’*). At the end of neurula-
tion (stage 20-21) the gene expression pattern of pdgf-b resulted 
 
Fig. 1. Platelet derived growth factor (PDGF) family members and 
their interactions. PDGF family is composed by the four ligands A, B, C 
and D that need to dimerize in order to be active and bind to the receptor. 
They can homodimerize and the only known heterodimer is AB. The two 
receptors, a and b, are tyrosine kinases and have different affinity for the 
ligands. When the ligand-receptor complex forms, the intracellular domains 
of the receptors trans-phosphorylate each other, triggering the signal. Ar-
rows indicate interaction, dashed arrows indicate hypothetical interactions.
Fig. 2. The temporal expression pattern of pdgfb revealed by qRT-PCR. 
Expression levels (y axis) of pdgf-b (red) and its receptor pdgfr-a (blue) at 
different developmental stages (x axis) were analyzed by qRT-PCR. The 
data are an average of three independent experiments, the values were 
normalized to odc and presented as mean ± s.d. Expression of pdgf-b 
mRNA reaches its maximum level as maternal transcript (stage 3), then 
drastically decreases during gastrulation (stage 10,5). A slight increase 
is observed during early neurulation (stage 13), however the expression 
becomes more robust at late neurula stage (stage 20) to decrease again 
in tailbud stages. Pdgfr-a,is barely detectable at stage 3 and then rise 
firmly already during gastrulation, reaching its maximum level at stage 20. 
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Fig. 3 (right). Pdgf-b spatial expression pattern during early stages of 
development in Xenopus laevis embryos. (A) Pdgf-b maternal transcript 
is distributed in the animal pole (arrow) at four cell stage (stage 3), lateral 
view. (B) Lateral view of a stage 10,5 embryo showing the pdgf-b mRNA 
localization in the animal pole of the embryo (arrow). (B’) Bisected gastrula 
showing the pdgf-b expression confined within the deep layer of the ecto-
dermal blastocoel roof (arrowheads). (A*)WISH performed using a pdgf-b 
sense riboprobe on a stage 3 embryo, lateral view. (B*) Stage 10,5 lateral 
view WISH using the pdgf-b sense riboprobe: no signal is detected in the 
animal pole. (B’*) Bisected gastrula showing no unspecific labelling of the 
blastocoel cavity using the pdgf-b sense riboprobe. (C) Late neurula,(stage 
20) embryo frontal view. Pdgf-b mRNA is localized in the CNS (midbrain–
hindbrain region: black and red arrowheads: the most ventral anterior region 
of neural tube: yellow arrow), the placode of the facial nerve (black arrow) 
and the notochord (inset). (D) Stage 20 frontal view double WISH: pdgf-b 
signal revealed in purple (black and red arrowheads), engrailed2 labelling 
the midbrain-hindbrain boundary and rombomere 1, in light blue. The two 
signals overlaps at the level of rhombomere 1. (E) Stage 20 frontal view 
double WISH: pdgf-b signal in purple (black and red arrowheads), krox20 
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Fig. 4. Pdgf-b expression spatial distribution in Xenopus 
laevis embryo at tailbud stage. (A) Pdgf-b mRNA is pres-
ent in the hindbrain (R1 and R3), the most ventral anterior 
region of the developing CNS (yellow arrow), the placode 
of the facial nerve (black arrow) and the notochord (inset, 
green arrowhead). (B-E) Double WISH was performed us-
ing different markers (the color code is described in Fig.3) 
at tailbud stage (stage 25). (B) Lateral view of an embryo 
processed by double WISH using twist as NCC marker.
(C) Pdgfr-a is expressed by NCC, in close proximity with 
the pdgf-b mRNA expression domain. (D-D’) Frontal and 
lateral views of the same embryo labelled to visualize rx1, 
a retinal marker (dashed oval identifies the eyefield) and 
pdgf-b. (E) A sagittal view of a half embryo bisected along 
the antero-posterior axis shows the expression of pdgf-b 
in the ventral telencephalon.
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labelling rhombomeres 3 (R3) and 5 (R5), in light blue. The two signals overlaps faintly at the level of rhombomere 3. (F) Double WISH using twist, a 
NCC marker in light blue. NCC are in close proximity of the pdgf-b expression domain but never overlap it. (G) Double WISH using pdgfr-a in light blue. 
Pdgfr-a is expressed in migrating NCC. (H) Frontal view of an embryo processed with double WISH using rx1, a marker for the eyefield (dashed oval), 
revealing a partial overlap of the pdgf-b signal (yellow arrow) with an anterior and ventral domain of the eyefield.
more robust and localized (Fig. 3C). At this stage, two stripes 
in the midbrain–hindbrain region of the central nervous system 
(CNS) are clearly defined and the placode of the facial nerve is 
labelled. We also observed a strongly labelled domain in anterior 
region of the neuroectoderm, possibly corresponding to the future 
telencephalon (Fig. 3 C-H). At the same stage, pdgf-b mRNA is 
also localized in the notochord (Fig. 3C inset). We then performed 
double WISH to better define pdgf-b expression territories in the 
CNS by using specific molecular markers to label respectively 
the midbrain-hindbrain boundary (engrailed2) and rhombomeres 
3 and 5 (krox20). Our data showed that pdgf-b mRNA localized in 
rhombomere 1 and rhombomere 3 of the hindbrain (Fig. 3 D-E). In 
order to define the identity of the most anterior pdgf-b expression 
domain, we also performed double WISH with the retinal marker 
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rx1, observing that pdgf-b partially overlapped rx1 
expression domain in the most medial domain of 
the eyefield (Fig. 3H). These data established the 
presence of pdgf-b mRNA within precise and con-
fined areas of the developing CNS, suggesting a 
potential role for pdgf-b in CNS development. This 
idea is supported also by previous data showing 
that the activity of the PDGF pathway is necessary 
to properly regulate oligodendrocyte progenitor 
cells (OPC) migration and proliferation (McKinnon 
et al., 2005) and that pdgf-b overexpression in vitro 
is sufficient to induce an OPC identity in neural 
progenitor cells (Appolloni et al., 2009). In addition, 
mutations in PDGF-B gene are responsible for 
causing primary familial brain calcification disease 
in humans (Keller et al., 2013). 
Different studies demonstrated that PDGF 
the most abundant glycosaminoglycan in the ECM surrounding 
cranial NCC. The developing NCC in Xenopus, in fact, produce 
hyaluronan and express the hyaluronan receptor CD44 (Casini 
et al., 2012). As the inhibition of the hyaluronan receptor CD44 
could in turn inhibit pdgf-b induced cell growth (Li et al., 2007), it 
is tempting to hypothesize a possible role of pdgf-b in the activa-
tion of CD44 to instruct cranial NCC to keep on dividing during 
their migration. In the future, it will be interesting to investigate by 
functional experiments whether pdgf-b signalling could be required 
to control these two key phenomena in NCC development: cell 
division and migration. 
Conclusions
The final result of this study was to unveil the gene expression 
pattern of pdgf-b during embryonic development. The possibility 
to have a vertebrate model such as Xenopus, in which the pdgf-b 
expression pattern is characterized, will allow future functional 
experiments aimed to clarify pdgf-b functions during brain and NCC 
development so far unsuspected. Moreover, overexpressing the 
PDGF-B mRNA in Xenopus embryos it will be possible to generate 
an alternative and useful model to study in vivo the pathogenic 
cellular mechanisms triggered by PDGF-B overexpression. 
Materials and Methods
Embryo preparation 
Animal procedures were performed in strict compliance with protocols 
approved by Italian Ministry of Public Health and of the local Ethical 
Committee of University of Pisa (authorization n.99/2012-A, 19.04.2012). 
Xenopus laevis embryos were obtained by hormone-induced laying and 
in vitro fertilization then reared in 0.1 X Marc’s Modified Ringer’s Solution 
(MMR 1×: 0.1 M NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES pH 7.5) till 
the desired stage according to Nieuwkoop and Faber (1967).
Quantitative reverse transcription polymerase chain reaction (qRT-
PCR)
Total RNA was extracted from 10 wild type embryos for each developmen-
tal stage examined with Nucleospin® RNA (Macherey-Nagel) according to 
the manufacturer’s instruction. cDNA was prepared by using iScript™ cDNA 
Synthesis Kit (Bio-Rad) and quantitative real-time PCR was performed using 
iQ™ SYBR® Green Supermix (Bio-Rad) according to the manufacturer’s 
instruction. mRNA levels were normalized to the housekeeping gene orni-
thine decarboxylase (odc). Three different couple of primers were used: odc 
Fig. 5. The cartoon represents the spatial relation between pdgf-b (red) and pdgfr-a 
(blue) mRNAs at neurula (stage 20) and tailbud (stage 26) stages. NCC:neural crest cells; 
nt: notochord; PPE: preplacodal ectoderm; R1 and R3: rhombomere 1 and 3; VII: facial nerve.
signalling is implicated in Neural Crest Cells (NCC) develop-
ment, but the mechanism of action remains controversial (Smith 
and Tallquist, 2010). In particular, the studies described so far 
were mainly focused on the role of pdgf-a and pdgfr-a during 
cranial NCC formation and migration (Eberhart et al., 2008, Ho 
et al., 1994), while a role for pdgf-b was supposed to be limited 
to a sub-population of cardiac NCC (Van den Akker et al., 2008). 
Cranial NCC are known to express pdgfr-a (Ho et al., 1994), that 
can activate an intracellular signalling cascade after the binding 
of pdgf-aa or pdgf-bb homodimers or the pdgf-ab heterodimer. In 
order to analyze the spatial relation between pdgf-b expression 
domain and NCC, we performed double WISH using twist, a NCC 
marker (Fig. 3F), or pdgfr-a (Fig. 3G). These analyses showed that 
pdgf-b mRNA was not expressed in NCC but in adjacent territories 
that can represent a source of pdgf-b during the early phases of 
NCC migration. In Xenopus, in fact, cranial NCC migrate from the 
mesencephalic and rhombencephalic regions of the CNS towards 
the branchial arches starting from late neurula (from stage 19). 
At the same stage, pdgf-b mRNA reaches its maximum expres-
sion level (Fig. 2). At tailbud stages (Stage 24-25) pdgf-b mRNA 
was still present in the same CNS territories described before, in 
the notochord and in the facial placode (Fig. 4A and the inset). 
Pdgf-b expression domain remained in close proximity to NCC, 
that are still migrating at this stage, but never overlaps them as 
shown by the double WISH performed with twist or pdgfr-a (Fig. 
4 B-C). The presence of pdgf-b in the facial placode suggested 
that it might contribute to the correct formation of the facial nerve 
that is composed both by an ectodermal derivative, the placode, 
and NCC. In order to better define the most anterior expression 
domain of pdgf-b in the CNS we repeated a double WISH at tailbud 
stage using the rx1 probe (Fig. 4 D-E). Pdgf-b mRNA expression 
domain partially overlaps with the most anterior-medial rx1 retinal 
expression domain (Fig. 4 D-D’) and in a medial-sagittal view of 
an embryo at the same stage, a clear pdgf-b labelling was visible 
also in the ventral telencephalon (Fig. 4E).
Taken together, these data unveiled the presence of pdgf-b 
mRNA in neuroectoderm derived structures during embryogenesis. 
On the basis of pdgf-b mRNA localization in a region adjacent to 
NCC expressing pdgfr-a, it is tempting to speculate that pdgf-b 
might also contribute to NCC development (Fig. 5). In this context it 
is interesting to remind that pdgf-b can bind to extracellular matrix 
components and that it can also stimulate hyaluronan synthesis, 
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and pdgfr-a sequences were reported in (Bae et al., 2014), while primers 
for pdgf-b were as follow: Forward 5’- GCTCTTCAATGCTCCTTTCC -3’, 
Reverse 5’- TGTGCAATAAGAGGGCAGTG -3’.
Whole mount in situ hybridization (WISH) 
Xenopus pdgf-b sequence was obtained via RT-PCR using the follow-
ing primers: forward, 5’- GAGATGTTCAAGAAGATCTCAG-3’; reverse, 
5’- CACTACGTGACCAAAAGTTCTC-3’. PCR product sequence was 
aligned to pdgf-b sequence (Gene Bank: NM_001094466) and then 
cloned into pGEM-T easy vector (Promega). Digoxigenin (DIG) (Roche) 
labelled sense and antisense RNA probes were generated for pdgf-b and 
Fluorescein (FLUO) (Roche) labelled antisense RNA probes were gener-
ated for twist, pdgfr-a, engrailed2, krox20 and rx1. WISH was performed 
as described (Reisoli et al., 2010). We first revealed the DIG probe signal 
with BM Purple (Roche) and then the FLUO probe signal was visualized 
using BCIP substrate (Roche). After colour development, embryos were 
post-fixed and bleached under fluorescent light to remove the pigment.
Acknowledgments
We are grateful to J.P. Saint-Jeannet (pdgfr-a), D. Alfandari (twist), D. 
Wilkinson (krox20), A. Hemmati Brivanlou (engrailed2) and M. Andreazzoli 
(rx1) for providing cDNAs for WISH. We thank M. Fabbri, G. De Matienzo 
and E. Landi for technical assistance and S. Di Maria for the frogs care. 
This work was supported by grants of “Ministero della Salute” (Italy) grant 
number GR-2008-1135643 and by Istituto Toscano Tumori Grant 2010 “Use 
of in vivo model systems for the study of PDGF induced glioma progression”.
References
ANDRAE, J., GOUVEIA, L., HE, L. and BETSHOLTZ, C. (2014). Characterization of 
platelet-derived growth factor-A expression in mouse tissues using a lacZ knock-in 
approach. PLoS One 9: e105477.
APPOLLONI, I., CALZOLARI, F., TUTUCCI, E., CAVIGLIA, S., TERRILE, M., CORTE, 
G. and MALATESTA, P. (2009). PDGF-B induces a homogeneous class of oligo-
dendrogliomas from embryonic neural progenitors. Int J Cancer 124: 2251-2259.
BAE, C.J., PARK, B.Y., LEE, Y.H., TOBIAS, J.W., HONG, C.S. and SAINT-JEANNET, 
J.P. (2014). Identification of Pax3 and Zic1 targets in the developing neural crest. 
Dev Biol 386: 473-483.
BETSHOLTZ, C. (1995). Role of plateled-dervided factors in mouse development. 
Int. J. Dev. Biol. 39: 817-825
CALZOLARI, F. and MALATESTA, P. (2010). Recent insights into PDGF-induced 
gliomagenesis. Brain Pathol 20: 527-538.
CASINI, P., NARDI, I. and ORI, M. (2012). Hyaluronan is required for cranial neural 
crest cells migration and craniofacial development. Dev Dyn 241: 294-302.
DAMM, E.W. and WINKLBAUER, R. (2011). PDGF-A controls mesoderm cell orientation 
and radial intercalation during Xenopus gastrulation. Development 138: 565-575.
DEMOULIN, J.B. and ESSAGHIR, A. (2014). PDGF receptor signaling networks in 
normal and cancer cells. Cytokine Growth Factor Rev 25: 273-283.
EBERHART, J.K., HE, X., SWARTZ, M.E., YAN, Y.L., SONG, H., BOLING, T.C., 
KUNERTH, A.K., WALKER, M.B., KIMMEL, C.B. and POSTLETHWAIT, J.H. 
(2008). MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis. Nat 
Genet 40: 290-298.
HELDIN, C.H. (2013). Targeting the PDGF signaling pathway in tumor treatment. 
Cell Commun Signal 11: 97.
HELDIN, C.H. (2014). Targeting the PDGF signaling pathway in the treatment of 
non-malignant diseases. J Neuroimmune Pharmacol 9: 69-79.
HO, L., SYMES, K., YORDAN, C., GUDAS, L.J. and MERCOLA, M. (1994). Lo-
calization of PDGF A and PDGFR alpha mRNA in Xenopus embryos suggests 
signalling from neural ectoderm and pharyngeal endoderm to neural crest cells. 
Mech Dev 48: 165-74.
HOCH, R.V. and SORIANO, P. (2003). Roles of PDGF in animal development. 
Development 130: 4769-4784.
KELLER, A., WESTENBERGER, A., SOBRIDO, M.J., GARCIA-MURIAS, M., DO-
MINGO, A., SEARS, R.L., LEMOS, R.R., ORDONEZ-UGALDE, A., NICOLAS, G., 
DA CUNHA, J.E. et al., (2013). Mutations in the gene encoding PDGF-B cause 
brain calcifications in humans and mice. Nat Genet 45: 1077-1082.
LEVEEN, P., PEKNY, M., GEBRE-MEDHIN, S., SWOLIN, B., LARSSON, E. and 
BETSHOLTZ, C. (1994). Mice deficient for PDGF B show renal, cardiovascular, 
and hematological abnormalities. Genes Dev 8: 1875-1887.
LI, L., ASTERIOU, T., BERNERT, B., HELDIN, C.H. and HELDIN, P. (2007). Growth 
factor regulation of hyaluronan synthesis and degradation in human dermal 
fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. 
Biochem J 404: 327-336.
MCKINNON, R.D., WALDRON, S. and KIEL, M.E. (2005). PDGF alpha-receptor 
signal strength controls an RTK rheostat that integrates phosphoinositol 3’-kinase 
and phospholipase Cgamma pathways during oligodendrocyte maturation. J 
Neurosci 25: 3499-3508.
NIEUWKOOP, P.D.F., J. (1967). Normal Table of Xenopus laevis (Daudin). Elsevier: 
Amsterdam, The Netherlands.
REISOLI, E., DE LUCCHINI, S., NARDI, I. and ORI, M. (2010). Serotonin 2B receptor 
signaling is required for craniofacial morphogenesis and jaw joint formation in 
Xenopus. Development 137: 2927-2937.
SMITH, C.L. and TALLQUIST, M.D. (2010). PDGF function in diverse neural crest 
cell populations. Cell Adh Migr 4: 561-566.
VAN DEN AKKER, N.M., WINKEL, L.C., NISANCIOGLU, M.H., MAAS, S., WISSE, 
L.J., ARMULIK, A., POELMANN, R.E., LIE-VENEMA, H., BETSHOLTZ, C. and 
GITTENBERGER-DE GROOT, A.C. (2008). PDGF-B signaling is important for 
murine cardiac development: its role in developing atrioventricular valves, coro-
naries, and cardiac innervation. Dev Dyn 237: 494-503.
Further Related Reading, published previously in the Int. J. Dev. Biol. 
Unraveling new roles for serotonin receptor 2B in development: key findings from Xenopus
Michela Ori, Stefania De Lucchini, Giulia Marras and Irma Nardi
Int. J. Dev. Biol. (2013) 57: 707-714
http://dx.doi.org/10.1387/ijdb.130204mo
The role of angiogenic growth factors in organogenesis
5 yr ISI Impact Factor (2013) = 2.879
Enrico Crivellato
Int. J. Dev. Biol. (2011) 55: 365-375
http://dx.doi.org/10.1387/ijdb.103214ec
Sequence and translation initiation properties of the Xenopus TGFbeta5, PDGF-A, and 
PDGF-alpha receptor 5’ untranslated regions
A W van der Velden, A Los, H O Voorma and A A Thomas
Int. J. Dev. Biol. (2000) 44: 851-859 
http://dx.doi.org/10.1387/ijdb. 11206326
Evidence that platelet derived growth factor (PDGF) action is required for mesoderm 
patterning in early amphibian (Xenopus laevis) embryogenesis
J S Ghil and H M Chung
Int. J. Dev. Biol. (1999) 43: 329-334 
http://dx.doi.org/10.1387/ijdb. 10470649
Role of platelet-derived growth factors in mouse development
C Betsholtz
Int. J. Dev. Biol. (1995) 39: 817-825 
http://dx.doi.org/10.1387/ijdb. 8645566
